The Engineering Research Center of polypeptide Drug Discovery and Evaluation of Jiangsu Province, College of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
Department of Bio-Treatment, Jinling Hospital, Nanjing, PR China.
Clin Immunol. 2019 Aug;205:116-124. doi: 10.1016/j.clim.2019.06.006. Epub 2019 Jun 19.
Autoimmune diseases are caused by self-immune responses to autoantigens, which damage body tissues and severely affect the patient's quality of life. Therapeutic drugs are associated with adverse side effects and their beneficial effects are limited to specific populations. Evidence indicates that exosomes which are small vesicles secreted by most cell types and body fluids, and may play roles in both immune stimulation and tolerance since they are involved in many processes such as immune signaling, inflammation and angiogenesis. Exosomes have also emerged as promising tools for therapeutic delivery, given their intrinsic features such as stability, biocompatibility and a capacity for stealth. In this review, we summarize existing literature regarding the production, efficacy, action mechanism, and potential therapeutic uses of exosomes in the contexts of autoimmune diseases such as type 1 diabetes mellitus, multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, and Sjogren's syndrome.
自身免疫性疾病是由自身免疫反应引起的,这些反应针对自身抗原,会损害身体组织,严重影响患者的生活质量。治疗药物与不良反应有关,其疗效仅限于特定人群。有证据表明,外泌体是大多数细胞类型和体液分泌的小囊泡,可能在免疫刺激和耐受中发挥作用,因为它们参与了许多过程,如免疫信号转导、炎症和血管生成。鉴于外泌体具有稳定性、生物相容性和隐身能力等固有特性,它们也已成为治疗性药物传递的有前途的工具。在这篇综述中,我们总结了关于外泌体在 1 型糖尿病、多发性硬化症、系统性红斑狼疮、类风湿关节炎和干燥综合征等自身免疫性疾病中的产生、疗效、作用机制和潜在治疗用途的现有文献。